RxDoctor Payments Data

Kalysia Zimmerman, PA

Physician Assistant · Grand Rapids, MINPI 1912427121

Payments from drug & device makers

$778in general payments, 2019–2025

Across 32 payments — averaging $24.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$170
  • AbbVie$170
  • Johnson & Johnson$134
  • Astellas Pharma US Inc$132
  • Janssen Scientific Affairs, LLC$39
  • Sumitomo Pharma America, Inc.$34
  • plus $100 from 5 others

What the payments were for

  • Food & beverage$64283%
  • Education$13617%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$778 in reported general payments places this provider in the 70th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$44,806
Medicare patients
251
Services billed
849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide27$405,048
GemtesaVibegron141$99,560
MyrbetriqMirabegron88$54,029
Methenamine Hippurate228$17,155
Tamsulosin Hcl360$7,288
Finasteride219$4,027
Estradiol52$3,172
Fosfomycin Tromethamine25$2,940
Alfuzosin Hcl ErAlfuzosin Hcl69$1,726
Trospium Chloride20$1,226
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst109$1,182
Potassium Citrate ErPotassium Citrate15$1,100
Trimethoprim30$1,002
Cephalexin71$471
Dutasteride16$463

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncXtandi, Myrbetriq$132$459,077115 claims
Sumitomo Pharma America, Inc.Gemtesa$34$99,560141 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →